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Abstract
Background: Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impairment
during endotoxemia and sepsis. Here we investigated if the renal circulatory and metabolic effects of endothelin during
endotoxemia are mediated through activation of endothelin-A receptors.
Methods and Findings: A randomized experimental study was performed with anesthetized and mechanically ventilated
pigs subjected to Escherichia coli endotoxin infusion for five hours. After two hours the animals were treated with the
selective endothelin receptor type A antagonist TBC 3711 (2 mg?kg
21, n=8) or served as endotoxin-treated controls (n=8).
Renal artery blood flow, diuresis and creatinine clearance decreased in response to endotoxemia. Perfusion in the cortex, as
measured by laser doppler flowmetry, was reduced in both groups, but TBC 3711 attenuated the decrease in the medulla
(p=0.002). Compared to control, TBC 3711 reduced renal oxygen extraction as well as cortical and medullary lactate/
pyruvate ratios (p,0.05) measured by microdialysis. Furthermore, TBC 3711 attenuated the decline in renal cortical
interstitial glucose levels (p=0.02) and increased medullary pyruvate levels (p=0.03). Decreased creatinine clearance and
oliguria were present in both groups without any significant difference.
Conclusions: These results suggest that endothelin released during endotoxemia acts via endothelin A receptors to impair
renal medullary blood flow causing ischemia. Reduced renal oxygen extraction and cortical levels of lactate by TBC 3711,
without effects on cortical blood flow, further suggest additional metabolic effects of endothelin type A receptor activation
in this model of endotoxin induced acute kidney injury.
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Introduction
Sepsis is a common cause of acute kidney injury (AKI). The
pathophysiology of septic AKI remains elusive but renal
impairment during sepsis has been postulated to be mediated by
kidney hypoperfusion owing to excessive renal vasoconstriction
[1]. Endothelin-1 (ET-1) was first described by Yanagisawa and
co-workers in 1988 and is a very potent endogenous vasoconstric-
tor [2]. Plasma levels of ET-1 is elevated in septic patients, mainly
through increased production, and also associated with severity of
the illness [3]. ET-1 mediates its effects through two different
receptors, endothelin type A receptor (ETA) and endothelin type B
receptor (ETB). In animal experiments of endotoxemia dual ETA/
ETB endothelin blockade has been described to improve
cardiopulmonary function [4], reduce pulmonary hypertension
[5] and lung injury [6], attenuate intestinal microcirculatory
dysfunction [7], reduce intestinal acidosis [8,9] and improve renal
function [10]. In the kidney, ET-1 may affect renal microcircu-
lation by constricting afferent and efferent arterioles through
activation of ETA [11]. Furthermore, ET-1 has tubular effects
favoring diuresis and natriuresis. This may be mediated by a
reduction of Na/K ATPase activity in the collecting ducts [12]
and also through an inhibitory effect on the opening of epithelial
Na channels by ETB [13]. A diuretic effect of ET-1 is suggested to
primarily be due to inhibition of arginine-vasopressin stimulated
water permeability by activation of ETB [14]. In addition, in rats
with diabetic renal injury selective ETA-antagonism have been
reported to reduce macrophage infiltration, suggesting that ETA
activation also contributes to renal inflammation [15].
We have previously shown that treatment with tezosentan, a
dual ETA/ETB antagonist, improves renal artery blood flow and
renal cortical microcirculation in endotoxemia, but has no effect
on urine production [16]. In the present study we hypothesized
that endothelin mediates renal microcirculatory impairment in
endotoxemia through activation of ETA and that treatment with
TBC 3711, a selective ETA antagonist, would improve renal
microcirculation and function. The theoretical rationale for this
was that the diuretic effects of ETB would be preserved whereas
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would be inhibited.
Materials and Methods
The experiments were conducted in accordance with ‘‘The
European Convention for Protection of Vertebrate Animals used
for Experimental and other Scientific Purposes’’ (Council of
Europe No 123, Strasbourg 1985). The study protocol was
approved by the Stockholm South Regional Ethics Committee for
Experiments in Animals, Huddinge District Court, Stockholm,
Sweden (Approval ID S-192-06). Sixteen crossbred (Landrace/
Yorkshire/Hampshire) female pigs weighing 33.360.7 kg were
used. Animals were fasted for solid food but had free access to
water for 24 h before surgery.
Surgical preparation
Anesthesia was initiated and maintained as previously described
in detail [16]. Anesthesia during surgical preparation was
maintained with sevoflurane (2.6% end-tidal concentration
(Et%), followed by 1.0 Et% throughout the experiment). Fentanyl
(10 mg?kg
21?h
21) and midazolam (0.15 mg?kg
21?h
21) was infused
throughout the experiment as a complement to sevoflurane and to
reduce surgically induced pain. Pancuronium bromide
(0.5 mg?kg
21?h
21) was given for muscle paralysis. After oral
intubation, ventilation with oxygen in air (FiO2 0.44) and a PEEP
of 4 cm H2O was initiated. Ventilation was adjusted to reach a
PCO2 of 4.7–5.3 kPa at baseline and the ventilator settings were
then kept constant throughout the experiment. During the surgical
preparation hydroxyethyl starch (130/0.4, 60 mg/ml, Voluven,
Fresenius Kabi, Uppsala, Sweden) and saline with glucose
(25 mg?ml
21) was infused continuously at 10 ml?kg
21?h
21 and
20 ml?kg
21?h
21, respectively.
Animals were placed in a supine position and the left carotid
artery was cannulated with a single lumen catheter for
measurement of arterial pressure and blood sampling. The jugular
vein on the left side was also catheterized and used for fluid
administration. A balloon-tipped pulmonary artery catheter (7.5F
Swan-Ganz, Edwards Lifesciences, Irvine, CA) was inserted into
the pulmonary artery via an introducer in the right jugular vein.
The position in the pulmonary artery was determined by pressure
guidance on a monitor. The different blood pressures were
measured via pressure transducers (DPT-6003, PVB Medizin
Technik, BMBH, Kirchseen, Germany). The pressure transducers
were calibrated to atmospheric pressure at the level of the heart
and to 100 mmHg or 25 mmHg using a saline column. After a
midline laparotomy, an ultrasonic flow probe (Transonic Systems
Inc, Ithaca, NY), was placed around the left renal artery and
connected to a recorder (T206, Transonic Systems Inc). The left
renal vein was visualized and an 18 Gauge catheter was inserted
into the vein and carefully fixated. The urinary bladder was
catheterized with a Foley catheter for hourly urine collection. The
left kidney was then exposed and a laser Doppler probe (0.25 mm
fiber separation, 780 nm wavelength; Perimed AB, Ja ¨rfa ¨lla,
Sweden) was sutured to the surface for cortical measurements. A
needle laser Doppler probe (0.15 mm fiber separation, 780 nm
wavelength) was then inserted 10–12 mm into the kidney for
medullary measurements. Position was confirmed visually by
opening the kidney post mortem. The two probes were connected
to a Periflux 5001 base unit (780 nm wavelength, 15 kHz band
width, 0.2-s time constant; Perimed AB). Calibration was
performed according to the manufacturer’s instructions. Two
microdialysis catheters (CMA 20, membrane length 10 mm, shaft
length 14 mm, diameter 0.5 mm, 20,000 Dalton membrane cut-
off, CMA Microdialysis, Stockholm, Sweden) was inserted in the
left kidney. First a small opening of the capsule was made with a
needle, thereafter one probe was inserted in the cortical region of
the kidney. The second microdialysis catheter was inserted in a
right angle in a separate opening of the capsule and placed in the
renal medulla. Position was confirmed visually by opening the
kidney post mortem. The two probes were continuously perfused
(CMA 402 syringe pump, CMA Microdialysis) at a speed of
1 ml?min
21 with a perfusion solution (T1 solution, 147 mM Na
+,
4m MK
+, 2.3 mM Ca
2+, and 156 mM Cl
2, CMA Microdialysis).
A stabilization period of 60 minutes was allowed before baseline
measurements. Samples were collected for 10 minutes at baseline,
120 and 300 minutes after start of endotoxemia. Adjustment for
time delay of samples reaching the vials was done. All samples
were analyzed immediately on a bench top analyzer (CMA 600
microdialysis analyzer, CMA Microdialysis). After surgical prep-
aration, the abdomen was carefully closed and the animals were
allowed 60 minutes of recovery before the initiation of the
experimental protocol. A continuous infusion of Ringers Acetate
(15 ml?kg
21?h
21) and saline with glucose 25 mg?ml
21
(5 ml?kg
21?h
21) was started directly after the surgery and kept
constant throughout the experiment.
Hemodynamic measurements and calculations
Hemodynamic measurements were acquired online (MP150,
Biopac Systems, Goleta, CA) with acquisition software (Acq-
Knowledge 3.7.3.; Biopac Systems) and stored on a computer.
Microcirculatory measurements were recorded online with
Perisoft for Windows (Perimed AB) data acquisition software.
Cardiac output was indexed to body surface area [17] and
presented as a cardiac index (CI). Renal artery blood flow (RBF)
was indexed to bodyweight. Creatinine clearance was calculated as
[(Urine flow 6Urine creatinine concentration)/plasma creatinine
concentration]. Renal vascular conductance was calculated as
RBF divided by the difference of MAP and renal venous pressure.
Oxygen delivery, oxygen consumption and oxygen extraction ratio
was calculated according to standard formulas for both systemic
and renal measurements.
Blood and plasma samples
Blood samples were collected in pre-chilled EDTA tubes and
immediately centrifuged at 3000 r.p.m. (200 g) for 15 min at 4uC
to obtain plasma. The plasma was stored at 80uC until assayed.
Plasma creatinine concentration was analyzed by the Jaffe method
(Synchron LX, Beckman Instruments, Richmond, CA). The
carotid blood samples were used for immediate arterial blood
gas analyses (ABL 77, Radiometer, Copenhagen, Denmark). In
addition, lactate (Accu-trend Lactate, Roche Diagnostics, Basel,
Switzerland) were analyzed using arterial blood. Renal vein
samples were analyzed for blood gases and lactate at baseline, 120
and 300 minutes after the infusion of endotoxin was initiated. ET-
1 levels in arterial blood and renal vein was measured by
radioimmunoassay as described earlier by Hemsen [18].
Experimental protocol
Baseline data were collected immediately prior to endotoxemia.
After baseline measurements all animals received a continuous
infusion of endotoxin (Escherichia coli lipopolysaccharide, sero-
type 0111:B4, 900 000 units?mg
21 endotoxin, Sigma-Aldrich
Sweden AB, Stockholm, Sweden). Endotoxin infusion was started
at 0.3125 mg ?kg
21?h
21 and was increased stepwise until reaching
2.5 mg?kg
21?h
21 after 30 min. It was then kept constant
throughout the experiment. After 120 minutes of endotoxemia
animals were randomized to receive treatment with the ETA
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21, Encysive Pharmaceuticals
Inc., Houston, TX,) 2 mg?kg
21 (n=8) or no treatment (endotoxin-
treated control, n=8). The dose of TBC 3711, not having any
ETB effect, was based on the results of an earlier study by our
group [7]. At the end of the experiment the animals were deeply
anesthetized and sacrificed by a lethal dose of sodium pentobar-
bital injected into a central vein.
Statistical analysis
All statistical calculations were performed using Statistica 8.0
(Statsoft Inc., Tulsa, OK) and the graphs were created with Sigma
Plot 11.0 (SPSS Inc., Chicago, IL). Data are expressed as means 6
standard error of the mean (SEM). Changes in parameters over
time were analysed according to a two-way repeated measures
ANOVA. Main effects (time and treatment) were analyzed with
time as a repeating variable before intervention, which included
the time-points baseline, 60 and 120 minutes, and after
intervention, which included the time-points 120, 180, 240 and
300 minutes, as within effects and treatment (control/TBC 3711)
as between effects. A significant interaction between time and
treatment was interpreted as a difference in the response to E.coli
LPS over time between the groups. The significance level was set
at p#0.05.
Results
Effect of endotoxin, (Baseline-120)
Systemic parameters. Infusion of endotoxin reduced
cardiac output, pH and increased heart rate, body temperature
and arterial lactate (p,0.001, for all, Table 1). Endotoxemia had
no significant effect on blood pressure (Figure 1). ET-1 levels in
plasma increased significantly (p,0.001, Table 1). Systemic
oxygen delivery, DO2sys and ERO2sys showed no significant
change but systemic oxygen uptake, VO2sys increased and base
excess decreased (data not shown).
Renal parameters. Renal blood flow and renal vascular
conductance increased significantly during the first two hours
(p,0.01, Figure 1 and p,0.001, Table 1). Endotoxemia also
resulted in an increased diuresis, fractional sodium excretion, FENa
(p,0.001, for both, Figure 2) and renal vein lactate (p,0.001,
Table 2). Laser Doppler flowmetry in renal cortex and medulla did
not change significantly for the first 120 minutes (Figure 1), nor did
creatinine clearance (Figure 2).
Renal oxygen delivery, DO2renal, increased (p,0.001 Table 2),
ERO2renal decreased but renal oxygen uptake VO2renal did not
change significantly (Figure 3, for both). For the interstitial fluid in
the renal cortex, glucosecort decreased whereas lactatecort and
pyruvatecort increased (p,0.001, for all three, Table 2). No
significant change in cortical lactate to pyruvate ratio, L/Pcort was
observed (Figure 3). In the medulla no changes in glucosemed or L/
Pmed ratio was observed, but a significant increase in both
lactatemed and pyruvatemed was seen (p,0.001, for both Table 2).
Effect of treatment (120–300)
Systemic parameters. Cardiac output continued to
decrease throughout the experiment and treatment with TBC
3711 had no significant effect on this decline (Table 1). However,
TBC 3711 reduced blood pressure significantly compared with the
control group (p,0.001, Figure 2). Tachycardia was present in
both groups and TBC 3711 treatment had no significant
chronotropic effect (Table 1). Body temperature increased in
both groups as well as arterial lactate (Table 1). TBC 3711
attenuated the decrease in pH (Table 1). ET-1 levels in arterial
plasma and renal vein remained elevated (p=0.001, Table 1)
throughout the experiment. Systemic extraction ratio increased
significantly as a result of a decreased oxygen delivery and
increased oxygen uptake in both groups (data not shown).
Renal parameters. Renal artery blood flow decreased as
well as renal vascular conductance with no significant effect of
TBC 3711 (Figure 1 and Table 1, respectively). Laser Doppler
flowmetry in the cortex decreased in both groups, but TBC 3711
abolished the decrease seen in the renal medulla (Figure 2). Renal
vein lactate increased with no significant group difference
(Table 2). Diuresis, creatinine clearance and fractional sodium
excretion was considerably reduced in both groups (Figure 2).
Renal oxygen delivery (Table 2) decreased to baseline levels in
both groups but renal oxygen uptake and renal oxygen extraction
ratio was significantly lower in the TBC 3711 group compared to
control (Figure 3, for both). Interstitial fluid levels of glucose in the
cortex decreased, but this was abolished by TBC 3711 (Table 2).
Treatment with TBC 3711 also attenuated the increase in cortical
interstitial fluid levels of lactate and as a result interstitial fluid
lactate/pyruvate (L/P) ratio was lower in the TBC 3711 treated
group (Table 2 and Figure 3). Cortical pyruvate levels increased as
a response to TBC3711 but were unchanged in the control group.
No significant change in interstitial fluid glucose but an increase in
lactate in both groups was seen in the medulla (Table 2, p,0.05
for both). However animals treated with TBC 3711 had a
significant increase in pyruvate, thus generating a significantly
lower L/P-ratio in the interstitial fluid (Table 2 and Figure 3).
Discussion
The present study aimed to investigate the role of endothelin in
mediating renal microcirculatory impairment through ETA
activation in endotoxin induced acute kidney injury. The main
finding was that treatment with an ETA-antagonist attenuated the
decline in renal medullary perfusion, which was also reflected by
signs of reduced ischemia in the medulla. This effect was
independent of changes in total renal blood flow and was not a
result of increased arterial blood pressure, suggesting that the effect
was mediated on a microcirculatory level. Furthermore, ETA-
receptor antagonism also attenuated renal oxygen extraction and
the L/P-ratio measured in the renal cortex, but had no significant
effect on diuresis or creatinine clearance.
Ischemia due to renal vasoconstriction is a plausible cause of
septic acute kidney injury [1], although other mechanisms have
been postulated as well [19]. Previously we have shown that
treatment with the dual ETA/ETB antagonist tezosentan
attenuates the decrease in total renal blood flow and renal cortical
microcirculation caused by endotoxemia [16]. These results were
not reproduced here. A reason for this may be that the effect on
cardiac index by the ETA-antagonist in this study was less
pronounced than the effect of tezosentan in the previous
investigation. Here we used TBC 3711, a highly selective ETA
antagonist with a selectivity of 441,000 fold for ETA over ETB. It
has previously been used to investigate ETA-mediated mecha-
nisms in pigs [7,20,21], including a recent report concerning
microcirculatory derangements in the gut during endotoxemia [7].
The dose of TBC 3711 used was chosen based on previous
experiments [7] and had no effect on plasma ET-1 levels. The
clearance of ET-1 from the circulation is suggested to be mediated
mainly by ETB receptors, and inhibition of ETB leads to
increasing levels of ET-1 in the circulation [22]. Thus, it appears
that no ETB antagonism was present after TBC 3711 adminis-
tration in the current experiments. A group treated with a selective
ETB-antagonist was not used as this has in previous experiments
drastically reduced survival in endotoxemic pigs [23].
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21534Figure 1. Renal hemodynamics. Changes in mean arterial blood pressure (MAP) (A), renal blood flow (RBF) (B), Laser Doppler flowmetry renal
cortex (LD Cortex) (C) and Laser Doppler flowmetry renal medulla (LD Medulla) (D) in response to lipopolysaccharide infusion and treatment with
either the selective ETA antagonist, TBC 3711 (2 mg?kg
21, n=8) or control (n=8). Data are expressed as mean 6 SEM. # indicates a significant
difference between TBC 3711 and control in response to lipopolysaccharide. (ANOVA repeated measures including 120, 180, 240 and 300). * indicates
a significant change in effect over time (120–300).
doi:10.1371/journal.pone.0021534.g001
Table 1. Systemic and renal parameters.
Group Baseline T60 T120 T180 T240 T300 p-value
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Cardiac Index Control 6,4 0,3 4,6 0,3 5,1 0,2 3,0 0,1 2,6 0,2 2,8 0,2
(l/min/m
2) TBC 6,4 0,3 5,3 0,3 4,9 0,3 3,3 0,3 2,7 0,3 3,0 0,3 0,67
Heart rate Control 100 4 115 8 136 6 148 9 169 10 178 8
(beatsNmin
21) TBC 100 5 121 7 150 9 160 11 171 12 168 13 0,09
Temperature Control 36,9 0,2 37,4 0,2 38,1 0,1 38,4 0,1 38,7 0,1 38,8 0,1
(uC) TBC 37,1 0,2 37,6 0,2 38,2 0,2 38,6 0,3 38,9 0,2 39,0 0,2 0,95
Lactatearterial Control 1,3 0,1 1,4 0,1 1,7 0,2 2,4 0,1 2,8 0,2 2,9 0,3
(mmol/l) TBC 1,2 0,1 1,3 0,1 2,0 0,2 2,5 0,2 2,8 0,3 2,5 0,2 0,21
pH Control 7,47 0,01 7,44 0,01 7,43 0,01 7,40 0,02 7,34 0,02 7,30 0,03
TBC 7,47 0,00 7,46 0,01 7,43 0,01 7,40 0,01 7,37 0,02 7,37 0,02 0,01
Plasma- ET-1 Control 7,5 0,5 9,0 1,4 20,0 0,9 17,7 1,1 19,9 2,4 16,9 0,8
(pmol/l) TBC 7,0 0,9 9,0 0,9 21,7 1,5 23,4 2,2 23,7 3,1 18,5 1,7 0,77
Renalvenous ET-1 Control 4,7 0,4 - - 13,5 2,7 - - - - 10,7 2,1
(pmol/l) TBC 5,0 0,4 - - 10,8 1,9 - - - - 13,1 3,1 0,06
RVC Control 2,1 0,1 1,8 0,1 2,6 0,2 2,0 0,1 1,8 0,1 1,6 0,1
(minNml
21NmmHg
21) TBC 2,1 0,1 2,0 0,2 2,9 0,2 2,8 0,3 2,2 0,2 2,1 0,3 0,28
Data are for TBC 3711 (TBC, n=8) and Control (n=8) expressed as mean 6 SEM. ANOVA repeated measures including 120, 180, 240 and 300 was performed. The
p-value refers to the time-treatment interaction using these time-points. Differences were considered significant at p#0.05. ET-1=Endothelin-1, RVC=Renal vascular
conductance,.
doi:10.1371/journal.pone.0021534.t001
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medullary perfusion in normotensive endotoxemic pigs due to
activation of ETA-receptors. This is in contrast to previous
findings in rats, where no change in medullary circulation was
observed as an effect of treatment with the ETA antagonist BQ-
123 in endotoxemia [24]. This discrepancy may reflect the fact
that medullary microvascular flow was not reduced by lipopoly-
saccharide per se in that study (ref 24). Furthermore, we used a
slightly longer observation period and as evident by Fig. 1D the
reduction in medullary flow occurred after more than 2 hours of
endotoxemia. The species difference could also be a factor since
potential disparities in the distribution of endothelin receptors in
the kidney between the rat and the pig may have functional
implications.
The maintained medullary perfusion in the treatment group
was not perfusion pressure dependent, since arterial pressure was
significantly reduced by TBC 3711. Moreover, no difference in
total renal blood flow was detected between groups indicating that
the effect of TBC 3711 was on a microcirculatory level. Under
normal physiological conditions intravenous infusion of ET-1
reduces medullary blood flow predominantly via ETA-activation
[25]. This has been suggested to be due to a decrease in blood flow
in the descending vasa recta [26], limiting the supply of blood to
the medulla and shunting it to more superficially situated
nephrons. The preservation of medullary microcirculation by
ETA antagonism in this study may also in part be due to excessive
stimulation of ETB when blocking ETA, thus promoting increased
medullary vasodilatation by ETB via NO. On the other hand,
increased ETB activity should have promoted other ETB
mediated effects, such as changes in diuresis or renal sodium
handling, which could not be detected in the present experiments.
Figure 2. Renal function parameters. Changes in Creatinine
clearance (A), Fractional excretion of sodium (FENA) (B) and diuresis
(C) in response to lipopolysaccharide infusion and treatment with either
the selective ETA antagonist, TBC 3711 (2 mg?kg
21, n=8) or control
(n=8) Data are expressed as mean 6 SEM. # indicates a significant
difference between TBC 3711 and control in response to lipopolysac-
charide. (ANOVA repeated measures including 120, 180, 240 and 300).
* indicates a significant change in effect over time (120–300).
doi:10.1371/journal.pone.0021534.g002
Table 2. Renal oxygen transport and metabolism.
Group Baseline 120 300
p-
value
Mean SEM Mean SEM Mean SEM
DO2renal Control 19,5 0,9 31,3 3,0 18,0 2,3
(mlNmin
21) TBC 20,9 1,1 35,2 1,9 16,8 3,0 0,10
Lactaterena-v Control 1,4 0,1 2,1 0,1 3,4 0,3
(mmol/1) TBC 1,5 0,1 2,2 0,2 2,8 0,2 0,08
ISF-Glucosecort Control 2,1 0,22 1,3 0,16 0,4 0,15
(mmol/l) TBC 2,2 0,17 1,5 0,13 1,4 0,17 0,02
ISF-Lactatecort Control 0,5 0,09 0,8 0,13 1,7 0,31
(mmol/1) TBC 0,4 0,04 0,8 0,05 1,1 0,12 0,03
ISF-Pyruvatecort Control 57 6 73 11 75 14
(mmol/l) TBC 41 4 69 7 99 5 0,05
ISF-Glucosemed Control 2,8 0,50 2,0 0,48 1,3 0,54
(mmol/l) TBC 2,8 0,32 2,5 0,29 2,1 0,48 0,27
ISF-Lactatemed Control 0,7 0,10 1,3 0,16 2,2 0,18
(mmol/l) TBC 0,9 0,05 1,2 0,14 2,2 0,28 0,93
ISF-Pyruvatemed Control 93 12 112 10 93 11
(mmol/l) TBC 98 16 125 17 159 24 0,01
Data are for TBC 3711 (TBC, n=8) and Control (n=8) expressed as mean 6 SEM.
ANOVA repeated measures including 120 and 300 was performed. The p-value
refers to the time-treatment interaction using these time-points. Differences
were considered significant at p#0.05. cort=cortex, DO2renal=Renal oxygen
delivery, ISF=Interstitial fluid, med=medulla.
doi:10.1371/journal.pone.0021534.t002
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kidney was increased, indicating that oxygen supply was not
impaired at the onset of renal damage. ETA antagonism was
associated with a reduced total renal oxygen extraction. As we
measured total renal oxygen delivery and consumption, we cannot
conclude if this reduction was a local medullary effect or if the
renal cortex was affected as well. The most obvious explanation for
a difference in renal oxygen consumption is a discrepancy in
reabsorption of sodium, as this is the most oxygen demanding
process in the kidney. However, there were no differences in
sodium handling between the groups that could explain the
difference in renal VO2. The natriuretic effect of ET-1 is also
assumed to be mediated largely through activation of ETB [13].
Furthermore, there were no changes in creatinine clearance or
renal blood flow which may also affect renal VO2. However, the
control animals developed a more significant acidosis compared to
TBC 3711-treated pigs, which may influence renal oxygen
handling [27]. Lower pH (or higher carbon dioxide) reduces the
binding affinity of oxygen to hemoglobin (Bohr effect [28]) and this
will result in more oxygen being released in the kidney when
metabolic demand increases. This effect has been highlighted in a
rat model [29], but the relative impact in the porcine kidney
remains to be explored.
Though no significant change in renal vein lactate was found in
these experiments, local interstitial lactate-differences in cortex
and medulla was observed with the use of microdialysis catheters.
Analysis of interstitial fluid with microdialysis makes it possible to
gain information about local metabolic changes and have been
used previously in endotoxemia [30]. Lactate, pyruvate as well as
the lactate/pyruvate ratio increased in both cortex and the
medulla in response to endotoxin in the control group, but not in
animals treated with TBC 3711. An elevated L/P ratio is usually
interpreted as a sign of anaerobic metabolism. As renal perfusion
decreased in control animals, ischemia is a likely cause of this effect
in the medulla. However, aerobic glycolysis also leads to increased
lactate levels without hypoxia in sepsis [31]. This non-anaerobic
mechanism for increased lactate may, in part, be an explanation to
our findings in the renal cortex where ETA-antagonism attenuated
the increase in L/P ratio, but had no apparent effect on the
microcirculatory blood flow. There was also a change in
metabolism in the cortex, as indicated by reduced glucose levels
and increased lactate levels. TBC 3711 attenuated the increase in
Figure 3. Renal oxygen transport and metabolism. Changes in lactate/pyruvate ratio cortex (L/P cortex) (A), lactate/pyruvate ratio medulla (L/P
medulla) (B), Renal oxygen consumption (VO2renal) (C) and Renal oxygen extraction (O2EXrenal) (D) in response to lipopolysaccharide infusion and
treatment with either the selective ETA antagonist, TBC 3711 (2 mg?kg 21, n=8) or control (n=8) Data are expressed as mean 6 SEM. # indicates a
significant difference between TBC 3711 and control in response to lipopolysaccharide. (ANOVA repeated measures including 120, 180, 240 and 300).
doi:10.1371/journal.pone.0021534.g003
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increase in pyruvate, indicating a preserved gluconeogenesis
converting lactate to pyruvate and subsequently glucose. Thus,
disturbed oxidative metabolism is, at least partly, a plausible
explanation for endotoxemia induced increase in L/P-ratio in the
renal cortex, and this may be improved by ETA-receptor
antagonism. However, further studies evaluating mitochondrial
function or ATP levels in renal tissue are needed to investigate this
hypothesis.
The hypothesis that selective ETA antagonism would improve
diuresis by preserving ETB function was not supported by the
experimental results. This may be due to an inadequate
observation period, but may also suggest that the relative
importance of using a specific ETA-antagonist, and thus not
inhibiting ETB, for maintaining diuresis during endotoxemia is
limited.
It is relevant to point out some limitations of this study. First,
this study was performed in anaesthetized animals and anaesthesia
per se has the potential to impair renal function in endotoxemia
[32]. However, the extensive and invasive methods used for renal
monitoring made general anesthesia necessary. No sham animals,
i.e. surgically instrumented pigs followed for 5 hours but without
endotoxin-infusion, were included in the study. It is reasonable to
assume that surgery per se had an effect on some of the measured
variables herein. This is a potential limitation as it is impossible to
entirely rule out that ETA-antagonism attenuated a reduction in
renal microcirculation caused by surgery. However, we find this
unlikely as a study using a 22-hour porcine model of endotoxemia
with similar instrumentation as the present investigation could not
demonstrate an effect of surgery [33]. Furthermore, in prior
studies by us in pigs, using the same degree of endotoxemia, the
response in renal hemodynamics and renal function was similar
although the renal instrumentation was less extensive compared to
the present investigation [34,35]. Another limitation is that urine
production and creatinine clearance, as well as the parameters
calculated from those measurements, reflects the function of both
kidneys but all measurements of renal hemodynamics and renal
metabolism were performed only on the left kidney. In addition,
there are limitations to the Laser Doppler flowmetry method,
which measures red blood cell velocity rather than quantitative
blood flow. This method of microcirculatory monitoring is also
unable to detect any heterogeneity in the renal microcirculation.
We conclude that TBC 3711, a selective ETA antagonist,
attenuates endotoxemia induced microcirculatory impairment and
ischemia in the renal medulla. Reduced total renal oxygen
extraction and cortical L/P-ratio by TBC 3711, without effects on
cortical blood flow, further suggest additional metabolic effects of
ETA activation. However, in the short-term perspective, selective
ETA-antagonism does not improve renal function in this model of
endotoxin induced acute kidney injury.
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